The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida
Moran R, Devchand M, Smibert O, Trubiano JA (2019) Antibiotic allergy labels in hospitalized and critically ill adults: a review of current impacts of inaccurate labeling
International travel with semaglutide International travel with semaglutide requires additional preparation because each country has different rules for bringing prescription medications
J Immunol 164(12):66476654 Lehmann DF (2012) The metabolic rationale for a lack of cross-reactivity between sulfonamide antimicrobials and other sulfonamide-containing drugs
PMID 2185014